Literature DB >> 25696316

Prehospital triage for angiography-guided therapy for acute myocardial infarction.

N M S K J Ernst, M J de Boer, A W J van 't Hof, F Hollak, H van de Wetering, J H E Dambrink, J C A Hoorntje, H Suryapranata, F Zijlstra.   

Abstract

BACKGROUND: Time between symptom onset and effective reperfusion is of paramount importance in patients with acute myocardial infarction (MI) treated with reperfusion therapy. In the PHIAT (Pre-Hospital Infarction Angioplasty Triage) project, safety and feasibility of in-ambulance electrocardiography facilities for prehospital triage for direct transfer to an interventional centre to undergo immediate coronary angiography and angiography-guided therapy were evaluated. METHODS AND
RESULTS: The ambulances were equipped with a defibrillator and electrocardiography unit with computerised electrocardiographic analysis. Patients with acute MI symptoms and fulfilling certain criteria compatible with a large MI were included and pretreated with heparin and aspirin during transportation. During the study period, 284 patients were included. Eleven percent did not have an acute MI. PCI, performed in 94% (n=239) of the patients, was successful in 94%. Prehospital triage reduced time to treatment. In 32% of the patients triage resulted in direct transportation to the interventional centre instead of to the nearest community hospital. All-cause mortality was 9% after a mean follow-up of nine months. No serious bleeding complications were seen.
CONCLUSION: Prehospital triage in the ambulance is safe and feasible. A striking percentage (11%) of the identified patients does not have an acute MI and this is more than has been reported from prehospital thrombolysis trials.

Entities:  

Keywords:  myocardial infarction; prehospital triage; primary angioplasty

Year:  2004        PMID: 25696316      PMCID: PMC2497087     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  22 in total

1.  Accuracy of a portable interpretive ECG machine in diagnosis of acute evolving myocardial infarction.

Authors:  M F O'Rourke; A Cook; G Carroll; D Gallagher; J Hall
Journal:  Aust N Z J Med       Date:  1992-02

2.  Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.

Authors:  P B Berger; S G Ellis; D R Holmes; C B Granger; D A Criger; A Betriu; E J Topol; R M Califf
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

3.  A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study.

Authors:  Cindy L Grines; Donald R Westerhausen; Lorelei L Grines; J Timothy Hanlon; Timothy L Logemann; Matti Niemela; W Douglas Weaver; Marianne Graham; Judith Boura; William W O'Neill; Carlos Balestrini
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

4.  [Twelve year triage and thrombolysis treatment prior to hospitalization for myocardial infarction patients in the Rotterdam area of the Netherlands: outstanding short-term and long-term results].

Authors:  E Boersma; A C Maas; J A Hartman; B Ilmer; J Vos; M L Simoons
Journal:  Ned Tijdschr Geneeskd       Date:  2001-10-20

5.  High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial.

Authors:  A Liem; F Zijlstra; J P Ottervanger; J C Hoorntje; H Suryapranata; M J de Boer; F W Verheugt
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

6.  Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction.

Authors:  F Zijlstra; A W van 't Hof; A L Liem; J C Hoorntje; H Suryapranata; M J de Boer
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

7.  Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT).

Authors:  J M Rawles
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

8.  A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.

Authors:  C L Grines; K F Browne; J Marco; D Rothbaum; G W Stone; J O'Keefe; P Overlie; B Donohue; N Chelliah; G C Timmis
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

9.  Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction.

Authors:  M J de Boer; H Suryapranata; J C Hoorntje; S Reiffers; A L Liem; K Miedema; W T Hermens; M J van den Brand; F Zijlstra
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

10.  Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival.

Authors:  M L Simoons; P W Serruys; M van den Brand; J Res; F W Verheugt; X H Krauss; W J Remme; F Bär; C de Zwaan; A van der Laarse
Journal:  J Am Coll Cardiol       Date:  1986-04       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.